ABT - Abbott Labs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABT - Abbott Labs

ABT 123.64

-0.9%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Masood Ahmed who wrote ()	3/24/2000 11:46:00 AM
From: Hamilton Rogers	Read Replies (3) of 328

Abbott Labs is a great company and is a teriffic buy under $35 per share, IMO. ABT has about a $500,000,000 REAGENT business segment which may show a slightly reduced growth rate in the future. New technology introduced by Luminex Corporation substantially reduces the quantity of REAGENT needed in biological activity testing. Luminex will begin trading on Tuesday the 28th with Warburg Dillon Read as underwriter. I started a thread for this company in the IPO category of SI. For other information on this security see their website. LMNX website: luminexcorp.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next